Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Adial Pharmaceuticals Inc (NASDAQ: ADIL) was $0.38 for the day, down -1.83% from the previous closing price of $0.39. In other words, the price has decreased by -$1.83 from its previous closing price. On the day, 1.0 million shares were traded. ADIL stock price reached its highest trading level at $0.3974 during the session, while it also had its lowest trading level at $0.367.
Ratios:
Our analysis of ADIL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.99 and its Current Ratio is at 1.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On October 30, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADIL now has a Market Capitalization of 5993264 and an Enterprise Value of 635694.
Stock Price History:
The Beta on a monthly basis for ADIL is 1.09, which has changed by -0.6082474 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, ADIL has reached a high of $1.30, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -12.85%, while the 200-Day Moving Average is calculated to be -49.98%.
Shares Statistics:
ADIL traded an average of 8.96M shares per day over the past three months and 6421890 shares per day over the past ten days. A total of 21.61M shares are outstanding, with a floating share count of 20.46M. Insiders hold about 5.35% of the company’s shares, while institutions hold 2.66% stake in the company. Shares short for ADIL as of 1752537600 were 341215 with a Short Ratio of 0.04, compared to 1749772800 on 490072. Therefore, it implies a Short% of Shares Outstanding of 341215 and a Short% of Float of 2.18.
Earnings Estimates
The dynamic stock of Adial Pharmaceuticals Inc (ADIL) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.09 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.55 and -$0.55 for the fiscal current year, implying an average EPS of -$0.55. EPS for the following year is -$1.0, with 1.0 analysts recommending between -$1.0 and -$1.0.
